Hosted on MSN3m
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Among the 10 drugs listed, Medicare Part D spent the most on Ozempic, Rybelsus and Wegovy, at $14.43 billion, according to a ...